Value & Innovation Forum

The Value & Innovation Forum is a collaboration of the National Forum for Heart Disease & Stroke Prevention and Patient Advocate Foundation, both 501(c)(3) nonprofit organizations. Briefing topics are selected by the Value & Innovation Forum Steering Committee which includes representatives of the Alliance of Community Health Plans, Association of Black Cardiologists, Caregiver Action Network, and National Osteoporosis Foundation, in addition to the National Forum and Patient Advocate Foundation. Briefings are made possible by funding from Amgen in accordance with the National Forum’s Policy on Corporate and Foundation Support and Relationships. This policy ensures transparency and integrity in the National Forum’s dealings with sponsors.

Briefings Archive

Telehealth: Patient Access & Equity - June 2, 2021

 

 

Webinar Recording
Webinar Summary

Speaker Bios

Shonta Chambers, MSW
Executive Vice President, Health Equity & Community Engagement
Principal Investigator, SelfMade Health Network
Patient Advocate Foundation

Barbara Hutchinson, MD PhD, FACC
President, Chesapeake Cardiac Care
Past President, Association of Black Cardiologists

Connie Hwang, MD, MPH
Chief Medical Officer, Director of Clinical Innovation
Alliance of Community Health Plans

Resources

Innovations and Alternatives to Traditional Utilization Management - December 14, 2020

Traditional utilization management has become burdensome for physicians and patients.  This 1-hour briefing brings forward innovative real-world examples to navigate utilization management.

Speakers
Kate Berry, Senior Vice President of Clinical Innovation, America’s Health Plans
Jay Scott, Director, Managed Care, Minnesota Oncology
Robin T. Zon, MD, FACP, FASCO Chair, ASCO Pathways Task Force
President, Finance & Quality Chair, Michiana Hematology-Oncology, PC

Moderator
Alan Balch, PhD, CEO, Patient Advocate Foundation, National Patient Advocate Foundation

Webinar Recording
Webinar Summary
Speaker Bios

Resources 

Sustaining Access & Choices for Patients: Exploring the Risks & Benefits of Traditional Medicare & Medicare Advantage - October 6, 2020

Increased focus on public options like “Medicare for All” along with historic increases in Medicare Advantage enrollment make this the right time for patient groups to learn more about different approaches and related policy issues!

Webinar Recording
     Welcome & Introduction (0:01)
     Tricia Neuman (4:25)
     Judith Stein (17:52)
     Michael Bagel (30:00)
     Discussion (40:00) 
Webinar Summary
Slides
Speaker Bios 

Resources 

Websites

Uptake and Pricing of Biosimilars & the "Rebate Wall": A Value & Innovation Forum Multi-Perspective Briefing - June 2, 2020

Biosimilars continue to be a controversial subject long after Congress created a pathway for their approval. The Value & Innovation Forum prides itself on creating forums that present all sides of an issue as well as new and interesting angles beyond the hotly debated. This session provides an interesting discussion about the “rebate wall” controversy in biosimilars, a patient perspective, and where the FDA is headed next.

Speakers

  • John M. Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention
  • Nicole Braccio, PharmD, Policy Director, National Patient Advocate Foundation
  • Christine Simmon, JD, Senior Vice President, Policy & Strategic Alliances, Executive Director, Biosimilars Council, Association for Accessible Medicines
  • Sarah Yim, MD, Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, Center for Drug Evaluation & Research, U.S. Food and Drug Administration
  • Chad Pettit, Executive Director, Global Value Access and Policy, Amgen
  • Madelaine Feldman, MD, Practicing Rheumatologist, Founding Member & Past President, Rheumatology Alliance of Louisiana

AGENDA

WELCOME

John M. ClymerJohn M. Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention
Bio


MODERATOR

Nicole Braccio, PharmD, Policy Director, National Patient Advocate Foundation
Bio

PANELISTS

Christine Simmon, Senior Vice President, Policy & Strategic Alliances, Executive Director, Biosimilars Council, Association for Accessible Medicines
Bio

Sarah Yim, MD, Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, Center for Drug Evaluation & Research, U.S. Food and Drug Administration
Bio 

Chad Pettit, Executive Director, Global Value Access and Policy, Amgen
Bio

Madelaine Feldman, MD, Practicing Rheumatologist, President, Coalition of State Rheumatology Organizations
Bio

Webinar Recording
Webinar Summary
Slides

Articles

White Paper

Websites

  • FDA Biosimilars for access to educational materials and information about biosimilar and interchangeable products.
  • Drugs@FDA for information on all FDA approved drug products, including labeling and review information.
  • FDA Advisory Committees for drug advisory committee meetings and materials related to biosimilars
  • FDA Purple Book a database of Licensed Biological Products for information on biological products, including if products are biosimilar to a reference product.
  • Amgen Biosimilars